Clinical Trial Update: Safety and Efficacy of the Combination of Tirabrutinib and Entospletinib With and Without Obinutuzumab in Adults With Chronic Lymphocytic Leukemia (CLL) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tirabrutinib plus entospletinib with or without obinutuzumab in adults with chronic lymphocytic leukemia; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Entospletinib (entospletinib)
• Obinutuzumab (obinutuzumab)
• Tirabrutinib (tirabrutinib)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2020-02-28